Time Commitment: 4.5 hours
Target Professions: MD, Nurse Practitioner, Nurse, Physician Assistant, DO
Target Specialties: Hematology, Hematology/Oncology, Oncology
Credits Available: 4.50 AMA PRA Category 1 Credit™, Maintenance of Certification (MOC) points available

Welcome to our interactive and engaging educational initiative on managing anemia in myelodysplastic syndromes (MDS). Anemia is a common issue in MDS, causing symptoms like fatigue, pallor, shortness of breath, and light-headedness. It can have a significant impact on patients' quality of life and lead to complications such as iron overload and red blood cell transfusion dependence. Moreover, anemia and transfusion dependence are associated with poor outcomes in MDS. In this program, you will learn the optimal time to initiate anemia treatment, how best to dose luspatercept and address adverse events, and familiarize yourself with emerging data in the treatment of anemia related to low-risk MDS to better help your patients.


CME/CE Accreditation Information

Self Study

Live Group Discussions

  • Exploring Your Experiences with MDS

    Considering the multi-faceted nature of MDS, let's explore the challenges and opportunities in managing this complex condition. Reflecting on your experiences & understanding of MDS, what do you think is most compelling and concerning?

  • Anemia in MDS: An In-Depth Discussion

    In this second group discussion, we will reflect on what we have learned and discuss best practices, implications of emerging data, and strategies to optimize patient outcomes.

Group Tasks

  • Richard, a 67-year-old man diagnosed with low-risk MDS

    Meet Richard, a 67-year-old man who has been diagnosed with low-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS).

My Action Plans

  • Your Action Plan - MDS

    Let's consider personal, practice, and system-based changes you can implement to improve outcomes for your patients with Myelodysplastic Syndromes (MDS)

Interested in becoming a Group Leader?

Requirements:
Group Leaders must be experts in the diagnosis, management, and treatment of myelodysplastic syndrome (MDS). Apply Now

Interested in participating in this curriculum? You can join one of the following groups:

Ashwin Kishtagari, MD
Assistant Professor of Medicine
Vernon Wu, MD
MD
Douglas Tremblay, MD
Assistant Professor
Catherine Lai, MD, MPH
Associate Professor/Physician Leader, Leukemia Clinical Research Unit
Kelly Chien, MD
Assistant Professor, Department of Leukemia
Harry Erba, MD, PhD
Professor of Medicine, Director of the Leukemia Program
Joshua Zeidner, MD
Associate Professor of Medicine
Brian Jonas, MD, PhD
Professor
Samuel Urrutia, MD
NG
Nicole Grieselhuber, MD PhD
Assistant Professor